Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Rachel A. Phelan MD, MPH

Rachel A. Phelan MD, MPH profile photo picture

Associate Professor

Institution: Medical College of Wisconsin
Department: Pediatrics
Division: Hematology and Oncology - Pediatrics
Program: Oncology

Member of the Cancer Center
Member of the Center for International Blood and Marrow Transplant Research (CIBMTR)

View Curriculum Vitae

Publications (81)

  • Assessing Physical Function in Transplantation and CAR-T Recipients: Expert Recommendations from the Survivorship, Aging and Biobehavioral Special Interest Groups of ASTCT. (Farhan S, Kennedy VE, Espinoza-Gutarra MR, Lust H, Bobillo MSO, Lin AY, Olin RL, Lin RJ, Rentscher KE, Taylor MR, Mohanraj L, Wood WA, Murthy HS, Ahmed N, Dueck AC, Phelan R, Kelly DL, Yuen C, Munshi PN, Schoemans H, Hamilton BK, Lee C, Sung AD) Transplant Cell Ther 2025 Jun 20 PMID: 40545000 06/23/2025    
  • Risk Factors for Solid Organ Graft Failure and Death in Hematopoietic Cell Transplant Recipients Undergoing Solid Organ Transplantation: A Retrospective Center for International Blood and Marrow Transplant Research and Organ Procurement and Transplantation Network Study. (Gupta M, Schoettler ML, Brazauskas R, Bo-Subait S, Orozco G, Battiwalla M, Buchbinder D, Hamilton BK, Savani BN, Schoemans H, Sorror ML, Ahmed S, Badawy SM, Bhushan V, Birdsey K, Couriel D, Doherty EE, Donato M, Farag SS, Gutman J, Horwitz M, El Jurdi N, Maakaron JE, Maziarz RT, Pineiro L, Schiller G, Weisdorf DJ, William BM, Shaw BE, Phelan R, Porter DL, Abt PL, Levine M) Transplantation 2025 Jun 23 PMID: 40545568 06/23/2025    
  • Risk Factors for Solid Organ Graft Failure and Death in Solid Organ Transplant Recipients Undergoing Hematopoietic Cell Transplantation: A Retrospective Center for International Blood and Marrow Transplant Research (CIBMTR) and Organ Procurement and Transplantation Network (OPTN) Study. (Gupta M, Schoettler ML, Orozco G, Brazauskas R, Bo-Subait S, Battiwalla M, Buchbinder D, Hamilton BK, Savani BN, Schoemans H, Sorror ML, Ahmed S, Badawy SM, Bhushan V, Birdsey K, Couriel D, Doherty EE, Donato M, Farag SS, Gutman J, Horwitz M, El Jurdi N, Maakaron JE, Maziarz RT, Pineiro L, Schiller G, Weisdorf DJ, William BM, Shaw BE, Phelan R, Porter DL, Levine M, Abt PL) Transplantation 2025 Jun 23 PMID: 40545567 06/23/2025    
  • Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy - A report from the CIBMTR. (R SS, S X, Temitope O, Woo AK, Othman A, Yung-Tsi B, Larisa B, Jenni B, Caitrin B, Min C, M DS, Najla EJ, Mehdi H, Mary H, H HA, Samantha J, Michelle K, J LS, Amy M, M PK, C PM, Waleska P, Rachel P, Doug R, Wael S, E SH, Patricia S, Eileen T, Alexis V, Rebecca V, J AJ, E SB, Mariam AJ) Transplant Cell Ther 2025 May 19 PMID: 40398621 05/22/2025    
  • Multicenter Study on Caregiver Experiences in Pediatric Hematopoietic Stem Cell Transplantation: Part II. Treatment Challenges, Communication Barriers, and Caregiver-Driven Approaches to Mitigation. (Phelan R, Rotz S, Dandoy CE, Auletta JJ, Badia P, Bhatt NS, Ballard SA, Blacken R, Daraiseh NM, Desmond C, Dunseath C, Epling P, Flesch L, Huber J, Jenssen K, Kapadia M, Kent G, Klunk A, Kusnier K, Lehmann L, Liberio N, Maier S, Myers KC, O'Connor G, Pai A, Tarquini S, Fitch TJ, Hartley D) Transplant Cell Ther 2025 May 10 PMID: 40355027 SCOPUS ID: 2-s2.0-105008143632 05/13/2025    
  • Multicenter Study on Caregiver Experiences in Pediatric Hematopoietic Stem Cell Transplantation Part I: Integrative Analysis of Mental Health, Psychosocial Stressors, and Support Mechanisms. (Bhatt NS, Lehmann L, Dandoy CE, Auletta JJ, Badia P, Ballard SA, Blacken R, Daraiseh NM, Desmond C, Dunseath C, Epling P, Fitch TJ, Flesch L, Hartley D, Huber J, Jenssen K, Kent G, Klunk A, Kapadia M, Kusnier K, Liberio N, Maier S, Myers KC, O'Connor G, Tarquini S, Phelan R, Pai A, Rotz S) Transplant Cell Ther 2025 Apr 21 PMID: 40268054 SCOPUS ID: 2-s2.0-105005847656 04/24/2025    
  • Engraft: A Collaborative Learning Health Network for Enhanced Transplant and Cellular Therapy Outcomes. (Dandoy CE, Auletta JJ, Badia P, Bidgoli A, Daraiseh NM, DeSalvo AM, Diaz J, Davies SM, Demmel K, Cook E, Craddock JA, Huber J, Sampson M, Fitch TJ, French K, Jodele S, Jaglowski SM, Kapadia MA, Khera N, Kent GR, Leung KS, Lehmann LE, Liang WH, Maier S, Nelson A, Nishitani M, O'Mathúna D, Johnson DJ, Magee K, Pai A, Parker LM, Phelan R, Epling P, Rotz S, Salem BM, Snyder A, Juckett M, Hartley D) Transplant Cell Ther 2025 Mar;31(3):123-134 PMID: 39743208 SCOPUS ID: 2-s2.0-85215570190 01/02/2025       2 Citations
  • Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-Versus-Host Disease Survivorship After Hematopoietic Cell Transplantation: Part IV. Patient Important Outcomes. (Rotz SJ, Wiener L, Baker KS, Choi SW, Phelan R, Cuvelier GDE, Duncan C, Williams KM, Qayed M) Transplant Cell Ther 2025 Apr;31(4):224.e1-224.e13 PMID: 39733839 PMCID: PMC11957933 SCOPUS ID: 2-s2.0-85215603300 12/30/2024    
  • Late effects after allogeneic haematopoietic cell transplantation in children and adolescents with non-malignant disorders: a retrospective cohort study. (Kahn J, Brazauskas R, Bo-Subait S, Buchbinder D, Hamilton BK, Schoemans H, Abraham AA, Agrawal V, Auletta JJ, Badawy SM, Beitinjaneh A, Bhatt NS, Broglie L, Diaz Perez MA, Farhadfar N, Freytes CO, Gale RP, Ganguly S, Hayashi RJ, Hematti P, Hildebrandt GC, Inamoto Y, Kamble RT, Koo J, Lazarus HM, Mayo SJ, Mehta PA, Myers KC, Nishihori T, Prestidge T, Rotz SJ, Savani BN, Schears RM, Sharma A, Stenger E, Ustun C, Williams KM, Vrooman LM, Satwani P, Phelan R) Lancet Child Adolesc Health 2024 Oct;8(10):740-750 PMID: 39217999 PMCID: PMC11588140 SCOPUS ID: 2-s2.0-85203761894 09/02/2024       1 Citation
  • Longitudinal clinical manifestations of Fanconi anemia: A systematized review. (Hoover A, Turcotte LM, Phelan R, Barbus C, Rayannavar A, Miller BS, Reardon EE, Theis-Mahon N, MacMillan ML) Blood Rev 2024 Nov;68:101225 PMID: 39107201 PMCID: PMC11568946 SCOPUS ID: 2-s2.0-85200556942 08/07/2024       8 Citations
  • Epidemiology of Diffuse Alveolar Hemorrhage in Pediatric Allogeneic Hematopoietic Cell Transplantation Recipients. (Cheng G, Smith MA, Phelan R, Brazauskas R, Strom J, Ahn KW, Hamilton B, Peterson A, Savani B, Schoemans H, Schoettler M, Sorror M, Higham C, Kharbanda S, Dvorak CC, Zinter MS) Transplant Cell Ther 2024 Oct;30(10):1017.e1-1017.e12 PMID: 39089527 PMCID: PMC11717115 SCOPUS ID: 2-s2.0-85202479318 08/02/2024       1 Citation
  • Impact of dexamethasone on transplant-related mortality in pediatric patients: a multi-site, propensity score-weighted, retrospective assessment. (Paw Cho Sing E, Tomlinson GA, Schechter T, Ali M, Phelan R, Rassekh SR, McKinnon K, Bier GA, van de Wetering M, Gomez S, Sung L, Dupuis LL) Support Care Cancer 2024 Jul 25;32(8):552 PMID: 39052128 SCOPUS ID: 2-s2.0-85199451194 07/26/2024    
  • Long-term outcomes among survivors of childhood osteosarcoma: A report from the Childhood Cancer Survivor Study (CCSS). (Becktell K, Chen Y, Yasui Y, Phelan R, Armstrong GT, Link M, Oeffinger K, Snyder C, Daw N, Weil B, Weldon C, Chow EJ, Schwartz CL) Pediatr Blood Cancer 2024 Oct;71(10):e31189 PMID: 39010279 PMCID: PMC11343645 SCOPUS ID: 2-s2.0-85198547860 07/16/2024       1 Citation
  • Current Trends and Outcomes in Cellular Therapy Activity in the United States, Including Prospective Patient-Reported Outcomes Data Collection in the Center for International Blood and Marrow Transplant Research Registry. (Cusatis R, Litovich C, Feng Z, Allbee-Johnson M, Kapfhammer M, Mattila D, Akinola I, Phelan R, Broglie L, Auletta JJ, Steinert P, Bolon YT, Akhtar O, Bloomquist J, Chen M, Devine SM, Bupp C, Hamadani M, Hengen M, Jaglowski S, Kaur M, Kuxhausen M, Lee SJ, Moskop A, Page KM, Pasquini MC, Rizzo D, Saber W, Spellman SR, Stefanski HE, Tuschl E, Yusuf R, Zhan K, Flynn KE, Shaw BE) Transplant Cell Ther 2024 Sep;30(9):917.e1-917.e12 PMID: 38944153 PMCID: PMC11587342 SCOPUS ID: 2-s2.0-85199289175 06/30/2024       32 Citations
  • Patient engagement in hematopoietic stem cell transplantation and cell therapy: a survey by the EBMT patient engagement task force & transplantation complications working party. (Schoemans H, Burns LJ, Liptrott SJ, Murray J, Kenyon M, Barata A, Bolaños N, Scholl I, Hamilton B, Phelan R, Buchbinder D, Penack O, Moiseev I, Boreland W, Peczynski C, De Geest S, Sureda A, Snowden JA, Shaw B, Peric Z, Kroeger N) Bone Marrow Transplant 2024 Sep;59(9):1286-1294 PMID: 38890544 PMCID: PMC11371514 SCOPUS ID: 2-s2.0-85196315053 06/19/2024       2 Citations
  • Leveraging Hematopoietic Cell Transplant Data and Biorepository Resources at the Center for International Blood and Marrow Transplant Research to Improve Patient Outcomes. (Bolon YT, Atshan R, Allbee-Johnson M, Estrada-Merly N, Auletta JJ, Broglie L, Cusatis R, Page KM, Phelan R, Sajulga R Jr, Shaw BE, Spahn A, Steinert P, Stewart V, Vierra-Green C, Lee SJ, Spellman SR) Transplant Cell Ther 2024 Sep;30(9):921.e1-921.e22 PMID: 38871054 PMCID: PMC11809440 SCOPUS ID: 2-s2.0-85198556368 06/14/2024       2 Citations
  • Pulmonary hypertension in the intensive care unit after pediatric allogeneic hematopoietic stem cell transplant: incidence, risk factors, and outcomes. (Smith MA, Cheng G, Phelan R, Brazauskas R, Strom J, Ahn KW, Hamilton BK, Peterson A, Savani B, Schoemans H, Schoettler ML, Sorror M, Keller RL, Higham CS, Dvorak CC, Fineman JR, Zinter MS) Front Oncol 2024;14:1415984 PMID: 38868534 PMCID: PMC11167102 SCOPUS ID: 2-s2.0-85195886044 06/13/2024    
  • Cumulative incidence estimates for solid tumors after HCT in the CIBMTR and California Cancer Registry. (Schonfeld SJ, Valcarcel B, Meyer CL, Shaw BE, Phelan R, Rizzo JD, Brunson A, Cooley JJP, Abrahão R, Wun T, Gadalla SM, Engels E, Albert PS, Yusuf R, Spellman SR, Curtis RE, Auletta JJ, Muffly L, Keegan THM, Morton LM) Blood Adv 2024 Aug 13;8(15):4102-4112 PMID: 38865710 PMCID: PMC11342185 SCOPUS ID: 2-s2.0-85201458048 06/12/2024    
  • Pathobiological signatures of dysbiotic lung injury in pediatric patients undergoing stem cell transplantation. (Zinter MS, Dvorak CC, Mayday MY, Reyes G, Simon MR, Pearce EM, Kim H, Shaw PJ, Rowan CM, Auletta JJ, Martin PL, Godder K, Duncan CN, Lalefar NR, Kreml EM, Hume JR, Abdel-Azim H, Hurley C, Cuvelier GDE, Keating AK, Qayed M, Killinger JS, Fitzgerald JC, Hanna R, Mahadeo KM, Quigg TC, Satwani P, Castillo P, Gertz SJ, Moore TB, Hanisch B, Abdel-Mageed A, Phelan R, Davis DB, Hudspeth MP, Yanik GA, Pulsipher MA, Sulaiman I, Segal LN, Versluys BA, Lindemans CA, Boelens JJ, DeRisi JL, Pediatric Transplantation and Cell Therapy Consortium) Nat Med 2024 Jul;30(7):1982-1993 PMID: 38783139 PMCID: PMC11271406 SCOPUS ID: 2-s2.0-85193908971 05/24/2024       3 Citations
  • International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update. (Rotz SJ, Bhatt NS, Hamilton BK, Duncan C, Aljurf M, Atsuta Y, Beebe K, Buchbinder D, Burkhard P, Carpenter PA, Chaudhri N, Elemary M, Elsawy M, Guilcher GMT, Hamad N, Karduss A, Peric Z, Purtill D, Rizzo D, Rodrigues M, Ostriz MBR, Salooja N, Schoemans H, Seber A, Sharma A, Srivastava A, Stewart SK, Baker KS, Majhail NS, Phelan R) Bone Marrow Transplant 2024 Jun;59(6):717-741 PMID: 38413823 PMCID: PMC11809468 SCOPUS ID: 2-s2.0-85186181200 02/28/2024       6 Citations
  • International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update. (Rotz SJ, Bhatt NS, Hamilton BK, Duncan C, Aljurf M, Atsuta Y, Beebe K, Buchbinder D, Burkhard P, Carpenter PA, Chaudhri N, Elemary M, Elsawy M, Guilcher GM, Hamad N, Karduss A, Peric Z, Purtill D, Rizzo D, Rodrigues M, Ostriz MBR, Salooja N, Schoemans H, Seber A, Sharma A, Srivastava A, Stewart SK, Baker KS, Majhail NS, Phelan R) Transplant Cell Ther 2024 Apr;30(4):349-385 PMID: 38413247 PMCID: PMC11181337 SCOPUS ID: 2-s2.0-85187940266 02/28/2024       6 Citations
  • Return to school practices after hematopoietic cell transplantation: a survey of transplant centers in the United States. (Bhatt NS, Meyer CL, Mau LW, Auletta JJ, Baker KS, Broglie L, Carpenter PA, Choi SW, Dandoy CE, Devine S, Phelan R) Bone Marrow Transplant 2024 May;59(5):653-659 PMID: 38378916 PMCID: PMC11299711 SCOPUS ID: 2-s2.0-85185254766 02/21/2024       5 Citations
  • Fertility Potential and Gonadal Function in Survivors of Reduced-Intensity Hematopoietic Stem Cell Transplantation. (Rotz SJ, Hamilton BK, Wei W, Ahmed I, Winston SA, Ballard S, Bernard RJ, Carpenter P, Farhadfar N, Ferraro C, Friend BD, Gloude NJ, Hayashi RJ, Hoyle K, Jenssen K, Koo J, Lee CJ, Mariano L, Nawabit R, Ngwube A, Lalefar N, Phelan R, Perkins L, Rao A, Rayes A, Sandheinrich T, Stafford L, Tomlinson K, Whiteside S, Wiedl C, Myers K) Transplant Cell Ther 2024 May;30(5):534.e1-534.e13 PMID: 38342136 PMCID: PMC11056299 SCOPUS ID: 2-s2.0-85186577512 02/12/2024       6 Citations
  • Incorporating patient-reported outcome data into a predictive calculator for allogeneic hematopoietic cell transplantation recipients. (Shaw BE, Flynn KE, He N, Cusatis R, D'Souza A, Hamilton BK, Horowitz MM, Mattila D, Phelan R, Lee SJ, Brazauskas R) Cancer 2024 May 15;130(10):1826-1835 PMID: 38198511 PMCID: PMC11058023 SCOPUS ID: 2-s2.0-85181878144 01/10/2024    
  • Graft-Versus-Host Disease, Rejection, and Venoocclusive Disease (Phelan RA, Margolis D) Nelson Textbook of Pediatrics Volume 1 2 1 January 2024:1356-1360.e1 SCOPUS ID: 2-s2.0-85206231885 01/01/2024    
  • Late Effects of Hematopoietic Stem Cell Transplantation (Phelan RA, Margolis D) Nelson Textbook of Pediatrics Volume 1 2 1 January 2024:1365-1366.e1 SCOPUS ID: 2-s2.0-85206229426 01/01/2024    
  • Hematopoietic Stem Cell Transplantation from Alternative Sources and Donors (Phelan RA, Margolis D) Nelson Textbook of Pediatrics Volume 1 2 1 January 2024:1355-1356.e1 SCOPUS ID: 2-s2.0-85206226827 01/01/2024    
  • Principles and Clinical Indications of Hematopoietic Stem Cell Transplantation (Phelan RA, Margolis D) Nelson Textbook of Pediatrics Volume 1 2 1 January 2024:1351-1354.e1 SCOPUS ID: 2-s2.0-85206223183 01/01/2024    
  • Intensive care risk and long-term outcomes in pediatric allogeneic hematopoietic cell transplant recipients. (Zinter MS, Brazauskas R, Strom J, Chen S, Bo-Subait S, Sharma A, Beitinjaneh A, Dimitrova D, Guilcher G, Preussler J, Myers K, Bhatt NS, Ringden O, Hematti P, Hayashi RJ, Patel S, De Oliveira SN, Rotz S, Badawy SM, Nishihori T, Buchbinder D, Hamilton B, Savani B, Schoemans H, Sorror M, Winestone L, Duncan C, Phelan R, Dvorak CC) Blood Adv 2024 Feb 27;8(4):1002-1017 PMID: 38127268 PMCID: PMC10879681 SCOPUS ID: 2-s2.0-85187724652 12/21/2023       16 Citations
  • Pulmonary microbiome and transcriptome signatures reveal distinct pathobiologic states associated with mortality in two cohorts of pediatric stem cell transplant patients. (Zinter MS, Dvorak CC, Mayday MY, Reyes G, Simon MR, Pearce EM, Kim H, Shaw PJ, Rowan CM, Auletta JJ, Martin PL, Godder K, Duncan CN, Lalefar NR, Kreml EM, Hume JR, Abdel-Azim H, Hurley C, Cuvelier GDE, Keating AK, Qayed M, Killinger JS, Fitzgerald JC, Hanna R, Mahadeo KM, Quigg TC, Satwani P, Castillo P, Gertz SJ, Moore TB, Hanisch B, Abdel-Mageed A, Phelan R, Davis DB, Hudspeth MP, Yanik GA, Pulsipher MA, Sulaiman I, Segal LN, Versluys BA, Lindemans CA, Boelens JJ, DeRisi JL, Pediatric Transplantation and Cell Therapy Consortium) medRxiv 2023 Nov 29 PMID: 38077035 PMCID: PMC10705623 12/11/2023    
  • Unfavorable transcriptome profiles and social disadvantage in hematopoietic cell transplantation: a CIBMTR analysis. (Taylor MR, Cole SW, Strom J, Brazauskas R, Baker KS, Phelan R, Buchbinder D, Hamilton B, Schoemans H, Shaw BE, Sharma A, Bhatt NS, Badawy SM, Winestone LE, Preussler JM, Mayo S, Jamani K, Nishihori T, Lee MA, Knight JM) Blood Adv 2023 Nov 28;7(22):6830-6838 PMID: 37773924 PMCID: PMC10679811 SCOPUS ID: 2-s2.0-85178332888 09/29/2023       6 Citations
  • Perspectives on Virtual Care for Childhood Cancer Survivors in Non-Metropolitan Areas during the COVID-19 Pandemic. (Phelan R, Aremu TO, Karst J, Anderson L, Jordan A, Morin J, Nichols J, Singh A, Schmidt D, Hoag JA, Napurski C, Zweber H, Sadak KT) Curr Oncol 2023 Sep 01;30(9):8111-8116 PMID: 37754503 PMCID: PMC10529011 SCOPUS ID: 2-s2.0-85172665792 09/27/2023       6 Citations
  • Critical Illness Risk and Long-Term Outcomes Following Intensive Care in Pediatric Hematopoietic Cell Transplant Recipients. (Zinter MS, Brazauskas R, Strom J, Chen S, Bo-Subait S, Sharma A, Beitinjaneh A, Dimitrova D, Guilcher G, Preussler J, Myers K, Bhatt NS, Ringden O, Hematti P, Hayashi RJ, Patel S, De Oliveira SN, Rotz S, Badawy SM, Nishihori T, Buchbinder D, Hamilton B, Savani B, Schoemans H, Sorror M, Winestone L, Duncan C, Phelan R, Dvorak CC) medRxiv 2023 Aug 05 PMID: 37577706 PMCID: PMC10418579 08/14/2023    
  • Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant Research. (Auletta JJ, Kou J, Chen M, Bolon YT, Broglie L, Bupp C, Christianson D, Cusatis RN, Devine SM, Eapen M, Hamadani M, Hengen M, Lee SJ, Moskop A, Page KM, Pasquini MC, Perez WS, Phelan R, Riches ML, Rizzo JD, Saber W, Spellman SR, Stefanski HE, Steinert P, Tuschl E, Yusuf R, Zhang MJ, Shaw BE) Transplant Cell Ther 2023 Jun;29(6):346.e1-346.e10 PMID: 36924931 PMCID: PMC10239334 SCOPUS ID: 2-s2.0-85153327578 03/17/2023       48 Citations
  • Next Steps: Survivor Healthcare Passport - A Novel Form of Survivorship Care Plan in the Pediatric Population. (Valencia MC, Hang L, Schmidt D, Nichols J, Zhang J, Yan K, Gonzalez A, Schwartz CL, Phelan R) J Pediatr Hematol Oncol 2023 Jul 01;45(5):e573-e577 PMID: 36898042 SCOPUS ID: 2-s2.0-85163834080 03/11/2023       2 Citations
  • Evaluation of a transition to survivorship program for pediatric, adolescent, and young adult cancer patients and caregivers. (Bingen K, Karst J, Anderson L, Chan S, Jordan A, Morin J, Nichols J, Palou-Torres A, Phelan R, Schmidt D, Yan K, Hoag JA) Pediatr Blood Cancer 2023 May;70(5):e30277 PMID: 36880713 SCOPUS ID: 2-s2.0-85150349486 03/08/2023       4 Citations
  • Relationship between work performance and quality of life in long-term survivors of pediatric and adolescent hematopoietic cell transplant. (Bhatt NS, Brazauskas R, Torres AP, Phelan R, Shaw BE) J Cancer Surviv 2024 Jun;18(3):772-780 PMID: 36585573 PMCID: PMC9803401 SCOPUS ID: 2-s2.0-85145237193 12/31/2022    
  • Biobehavioral Implications of Chimeric Antigen Receptor T-cell Therapy: Current State and Future Directions. (Taylor MR, Steineck A, Lahijani S, Hall AG, Jim HSL, Phelan R, Knight JM) Transplant Cell Ther 2023 Jan;29(1):19-26 PMID: 36208728 SCOPUS ID: 2-s2.0-85143519815 10/09/2022       6 Citations
  • Corrigendum to 'Current Use and Trends in Hematopoietic Cell Transplantation in the United States' [Transplantation and Cellular Therapy 26/8 (2020) e177-e182]. (D'Souza A, Fretham C, Lee SJ, Arora M, Brunner J, Chhabra S, Devine S, Eapen M, Hamadani M, Hari P, Pasquini MC, Perez W, Phelan RA, Riches ML, Rizzo JD, Saber W, Shaw BE, Spellman SR, Steinert P, Weisdorf DJ, Horowitz MM) Transplant Cell Ther 2022 Oct;28(10):715-716 PMID: 36202526 SCOPUS ID: 2-s2.0-85108559179 10/07/2022       2 Citations
  • Chronic conditions, late mortality, and health status after childhood AML: a Childhood Cancer Survivor Study report. (Turcotte LM, Whitton JA, Leisenring WM, Howell RM, Neglia JP, Phelan R, Oeffinger KC, Ness KK, Woods WG, Kolb EA, Robison LL, Armstrong GT, Chow EJ) Blood 2023 Jan 05;141(1):90-101 PMID: 36037430 PMCID: PMC9837436 SCOPUS ID: 2-s2.0-85145310573 08/30/2022       6 Citations
  • Secondary Impact of the Coronavirus Disease 19 Pandemic on Patients and the Cellular Therapy Healthcare Ecosystem. (Koo J, Auletta JJ, Hartley DM, Huber J, Jaglowski S, Kapadia M, Kusnier K, Lehmann L, Maakaron J, Myers KC, Pai A, Parker L, Phelan R, Sper C, Rotz SJ, Dandoy CE) Transplant Cell Ther 2022 Nov;28(11):737-746 PMID: 35902050 PMCID: PMC9313529 SCOPUS ID: 2-s2.0-85136675259 07/29/2022       7 Citations
  • Male-specific late effects in adult hematopoietic cell transplantation recipients: a systematic review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation. (Phelan R, Im A, Hunter RL, Inamoto Y, Lupo-Stanghellini MT, Rovo A, Badawy SM, Burns L, Eissa H, Murthy HS, Prasad P, Sharma A, Suelzer E, Agrawal V, Aljurf M, Baker K, Basak GW, Buchbinder D, DeFilipp Z, Grkovic LD, Dias A, Einsele H, Eisenberg ML, Epperla N, Farhadfar N, Flatau A, Gale RP, Greinix H, Hamilton BK, Hashmi S, Hematti P, Jamani K, Maharaj D, Murray J, Naik S, Nathan S, Pavletic S, Peric Z, Pulanic D, Ross R, Salonia A, Sanchez-Ortega I, Savani BN, Schechter T, Shah AJ, Smith SM, Snowden JA, Steinberg A, Tremblay D, Vij SC, Walker L, Wolff D, Yared JA, Schoemans H, Tichelli A) Bone Marrow Transplant 2022 Jul;57(7):1150-1163 PMID: 35523848 PMCID: PMC10316716 SCOPUS ID: 2-s2.0-85129492511 05/07/2022       13 Citations
  • Updated Trends in Hematopoietic Cell Transplantation in the United States with an Additional Focus on Adolescent and Young Adult Transplantation Activity and Outcomes. (Phelan R, Chen M, Bupp C, Bolon YT, Broglie L, Brunner-Grady J, Burns LJ, Chhabra S, Christianson D, Cusatis R, Devine SM, D'Souza A, Eapen M, Hamadani M, Hengen M, Lee SJ, Moskop A, Page KM, Pasquini M, Pérez WS, Riches M, Rizzo D, Saber W, Spellman SR, Stefanski HE, Steinert P, Weisdorf D, Horowitz M, Auletta JJ, Shaw BE, Arora M) Transplant Cell Ther 2022 Jul;28(7):409.e1-409.e10 PMID: 35447374 PMCID: PMC9840526 SCOPUS ID: 2-s2.0-85130441260 04/22/2022       51 Citations
  • Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy: Using the Model for Improvement to impact Outcomes. (Kapadia M, Lehmann L, Auletta J, Beatty L, Bhatt N, Blacken R, Demmel K, Dodd T, Desmond C, Fitch T, Flesch L, Hartley D, Huber J, Ingraham H, Jakubowski R, Klunk A, Krupski C, Kusnier K, Liberio N, Maakaron J, Mueller M, Myers KC, Pai A, Parker L, Patel S, Phelan R, Polishchuk V, Sigmund A, Sper C, Tarquini S, Juckett M, Jaglowski S, Dandoy C, Rotz S) Transplant Cell Ther 2022 May;28(5):233-241 PMID: 35151937 SCOPUS ID: 2-s2.0-85126771134 02/14/2022       11 Citations
  • Male-Specific Late Effects in Adult Hematopoietic Cell Transplantation Recipients: A Systematic Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation. (Phelan R, Im A, Hunter RL, Inamoto Y, Lupo-Stanghellini MT, Rovo A, Badawy SM, Burns L, Eissa H, Murthy HS, Prasad P, Sharma A, Suelzer E, Agrawal V, Aljurf M, Baker K, Basak GW, Buchbinder D, DeFilipp Z, Grkovic LD, Dias A, Einsele H, Eisenberg ML, Epperla N, Farhadfar N, Flatau A, Gale RP, Greinix H, Hamilton BK, Hashmi S, Hematti P, Jamani K, Maharaj D, Murray J, Naik S, Nathan S, Pavletic S, Peric Z, Pulanic D, Ross R, Salonia A, Sanchez-Ortega I, Savani BN, Schechter T, Shah AJ, Smith SM, Snowden JA, Steinberg A, Tremblay D, Vij SC, Walker L, Wolff D, Yared JA, Schoemans H, Tichelli A) Transplant Cell Ther 2022 Jun;28(6):335.e1-335.e17 PMID: 34757220 PMCID: PMC9050968 SCOPUS ID: 2-s2.0-85127295019 11/11/2021       10 Citations
  • Return-to-School Practices for Pediatric Hematopoietic Cell Transplantation Recipients during the COVID-19 Pandemic. (Bhatt NS, Meyer C, Mau LW, Broglie L, Devine S, Choi SW, Auletta J, Phelan R) Transplant Cell Ther 2022 Jan;28(1):54.e1-54.e4 PMID: 34543770 PMCID: PMC8447546 SCOPUS ID: 2-s2.0-85119175199 09/21/2021       5 Citations
  • Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year. (Heslop HE, Stadtmauer EA, Levine JE, Ballen KK, Chen YB, DeZern AE, Eapen M, Hamadani M, Hamilton BK, Hari P, Jones RJ, Logan BR, Kean LS, Leifer ES, Locke FL, Maziarz RT, Nemecek ER, Pasquini M, Phelan R, Riches ML, Shaw BE, Walters MC, Foley A, Devine SM, Horowitz MM) Transplant Cell Ther 2021 Nov;27(11):885-907 PMID: 34461278 PMCID: PMC8556300 SCOPUS ID: 2-s2.0-85116810681 08/31/2021       13 Citations
  • Systematic Reviews in Hematopoietic Cell Transplantation and Cellular Therapy: Considerations and Guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and Center for International Blood and Marrow Transplant Research Late Effects and Quality of Life Working Committee. (Sharma A, Badawy SM, Suelzer EM, Murthy HS, Prasad P, Eissa H, Carpenter PA, Hamadani M, Labopin M, Schoemans H, Tichelli A, Phelan R, Hamilton BK, Buchbinder D, Im A, Hunter R, Brazauskas R, Burns LJ) Transplant Cell Ther 2021 May;27(5):380-388 PMID: 33965174 PMCID: PMC8415092 SCOPUS ID: 2-s2.0-85101079037 05/10/2021       4 Citations
  • Correction: Systematic reviews in hematopoietic cell transplantation and cellular therapy: considerations and guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and the Center for International Blood and Marrow Transplant Research late effects and quality of life working committee. (Sharma A, Badawy SM, Suelzer EM, Murthy HS, Prasad P, Eissa H, Carpenter PA, Hamadani M, Labopin M, Schoemans H, Tichelli A, Phelan R, Hamilton BK, Buchbinder D, Im A, Hunter R, Brazauskas R, Burns LJ) Bone Marrow Transplant 2021 Jun;56(6):1486 PMID: 33941873 SCOPUS ID: 2-s2.0-85105183322 05/05/2021       2 Citations
  • Systematic Reviews in Hematopoietic Cell Transplantation and Cellular Therapy: Considerations and Guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and Center for International Blood and Marrow Transplant Research Late Effects and Quality of Life Working Committee (Sharma A, Badawy SM, Suelzer EM, Murthy HS, Prasad P, Eissa H, Carpenter PA, Hamadani M, Labopin M, Schoemans H, Tichelli A, Phelan R, Hamilton BK, Buchbinder D, Im A, Hunter R, Brazauskas R, Burns LJ) Transplantation and Cellular Therapy May 2021;27(5):380-388 SCOPUS ID: 2-s2.0-85101079037 05/01/2021       4 Citations
  • Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United States. (Bhatt NS, Brazauskas R, Salit RB, Syrjala K, Bo-Subait S, Tecca H, Badawy SM, Baker KS, Beitinjaneh A, Bejanyan N, Byrne M, Dias A, Farhadfar N, Freytes CO, Ganguly S, Hashmi S, Hayashi RJ, Hong S, Inamoto Y, Jamani K, Kasow KA, Khera N, Krem MM, Lazarus HM, Lee CJ, Lee S, Majhail NS, Malone AK, Marks DI, Mau LW, Mayo SJ, Muffly LS, Nathan S, Nishihori T, Page KM, Preussler J, Rangarajan HG, Rotz SJ, Salooja N, Savani BN, Schears R, Schechter-Finkelstein T, Schiller G, Shah AJ, Sharma A, Wang T, Wirk B, Battiwalla M, Schoemans H, Hamilton B, Buchbinder D, Phelan R, Shaw B) Transplant Cell Ther 2021 Aug;27(8):679.e1-679.e8 PMID: 33895402 PMCID: PMC8425287 SCOPUS ID: 2-s2.0-85107434203 04/26/2021       15 Citations
  • Case Series: Development of Polyps as a Late Effect After Total Body Irradiation-based Hematopoietic Cell Transplantation in Children With High-risk Leukemia. (Knight B, Anderson L, Lerner D, Phelan R, Thakar MS) J Pediatr Hematol Oncol 2021 Nov 01;43(8):e1159-e1163 PMID: 33828034 PMCID: PMC8492786 SCOPUS ID: 2-s2.0-85120523873 04/09/2021       2 Citations
  • A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant. (Dandoy CE, Rotz S, Alonso PB, Klunk A, Desmond C, Huber J, Ingraham H, Higham C, Dvorak CC, Duncan C, Schoettler M, Lehmann L, Cancio M, Killinger J, Davila B, Phelan R, Mahadeo KM, Khazal S, Lalefar N, Vissa M, Myers K, Wallace G, Nelson A, Khandelwal P, Bhatla D, Gloude N, Anderson E, Huo J, Roehrs P, Auletta JJ, Chima R, Lane A, Davies SM, Jodele S) Blood Adv 2021 Jan 12;5(1):1-11 PMID: 33570619 PMCID: PMC7805323 SCOPUS ID: 2-s2.0-85099262070 02/12/2021       69 Citations
  • Systematic reviews in hematopoietic cell transplantation and cellular therapy: considerations and guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and the Center for International Blood and Marrow Transplant Research late effects and quality of life working committee. (Sharma A, Badawy SM, Suelzer EM, Murthy HS, Prasad P, Eissa H, Carpenter PA, Hamadani M, Labopin M, Schoemans H, Tichelli A, Phelan R, Hamilton BK, Buchbinder D, Im A, Hunter R, Brazauskas R, Burns LJ) Bone Marrow Transplant 2021 Apr;56(4):786-797 PMID: 33514917 PMCID: PMC8168056 SCOPUS ID: 2-s2.0-85099909157 01/31/2021       6 Citations
  • A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant (Dandoy CE, Rotz S, Alonso PB, Klunk A, Desmond C, Huber J, Ingraham H, Higham C, Dvorak CC, Duncan C, Schoettler M, Lehmann L, Cancio M, Killinger J, Davila B, Phelan R, Mahadeo KM, Khazal S, Lalefar N, Vissa M, Myers K, Wallace G, Nelson A, Khandelwal P, Bhatla D, Gloude N, Anderson E, Huo J, Roehrs P, Auletta JJ, Chima R, Lane A, Davies SM, Jodele S) Blood Advances 12 January 2021;5(1):1-11 SCOPUS ID: 2-s2.0-85099262070 01/12/2021       69 Citations
  • International Blood and Marrow Registries: trends on long-term data collection (Phelan R, Passweg JR, Baldomero H, Iida M, Atsuta Y, Okamoto S, Aljurf M, Alfraih F, Shaw BE) Blood and Marrow Transplantation Long Term Management Survivorship After Transplant Second Edition 1 January 2021:6-13 SCOPUS ID: 2-s2.0-85152309078 01/01/2021       1 Citation
  • Infection prophylaxis patterns following pediatric autologous hematopoietic stem cell transplantation: A survey of Pediatric Transplant and Cell Therapy Consortium centers (Falcon CP, Broglie L, Phelan R, Choi SW, Auletta JJ, Chewning JH) Pediatric Transplantation December 2020;24(8) SCOPUS ID: 2-s2.0-85089827784 12/01/2020       4 Citations
  • Chimeric antigen receptor T-cell therapy for marrow and extramedullary relapse of infant acute lymphoblastic leukemia. (Moskop A, Pommert L, Thakrar P, Talano J, Phelan R) Pediatr Blood Cancer 2021 Jan;68(1):e28739 PMID: 33009894 SCOPUS ID: 2-s2.0-85091860342 10/04/2020       10 Citations
  • Correction: Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT. (Marsh RA, Leiding JW, Logan BR, Griffith LM, Arnold DE, Haddad E, Falcone EL, Yin Z, Patel K, Arbuckle E, Bleesing JJ, Sullivan KE, Heimall J, Burroughs LM, Skoda-Smith S, Chandrakasan S, Yu LC, Oshrine BR, Cuvelier GDE, Thakar MS, Chen K, Teira P, Shenoy S, Phelan R, Forbes LR, Martinez C, Chellapandian D, Dávila Saldaña BJ, Shah AJ, Weinacht KG, Joshi A, Boulad F, Quigg TC, Dvorak CC, Grossman D, Torgerson T, Graham P, Prasad V, Knutsen A, Chong H, Miller H, de la Morena MT, DeSantes K, Cowan MJ, Notarangelo LD, Kohn DB, Stenger E, Pai SY, Routes JM, Puck JM, Kapoor N, Pulsipher MA, Malech HL, Parikh S, Kang EM, submitted on behalf of the Primary Immune Deficiency Treatment Consortium) J Clin Immunol 2020 Nov;40(8):1211-1213 PMID: 32860171 PMCID: PMC11060430 SCOPUS ID: 2-s2.0-85089900632 08/30/2020       2 Citations
  • Infection prophylaxis patterns following pediatric autologous hematopoietic stem cell transplantation: A survey of Pediatric Transplant and Cell Therapy Consortium centers. (Falcon CP, Broglie L, Phelan R, Choi SW, Auletta JJ, Chewning JH) Pediatr Transplant 2020 Dec;24(8):e13821 PMID: 32844543 SCOPUS ID: 2-s2.0-85089827784 08/28/2020       4 Citations
  • Current Use of and Trends in Hematopoietic Cell Transplantation in the United States. (D'Souza A, Fretham C, Lee SJ, Arora M, Brunner J, Chhabra S, Devine S, Eapen M, Hamadani M, Hari P, Pasquini MC, Perez W, Phelan RA, Riches ML, Rizzo JD, Saber W, Shaw BE, Spellman SR, Steinert P, Weisdorf DJ, Horowitz MM) Biol Blood Marrow Transplant 2020 Aug;26(8):e177-e182 PMID: 32438042 PMCID: PMC7404814 SCOPUS ID: 2-s2.0-85085969206 05/22/2020       415 Citations
  • Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases. (Kahn JM, Brazauskas R, Tecca HR, Bo-Subait S, Buchbinder D, Battiwala M, Flowers MED, Savani BN, Phelan R, Broglie L, Abraham AA, Keating AK, Daly A, Wirk B, George B, Alter BP, Ustun C, Freytes CO, Beitinjaneh AM, Duncan C, Copelan E, Hildebrandt GC, Murthy HS, Lazarus HM, Auletta JJ, Myers KC, Williams KM, Page KM, Vrooman LM, Norkin M, Byrne M, Diaz MA, Kamani N, Bhatt NS, Rezvani A, Farhadfar N, Mehta PA, Hematti P, Shaw PJ, Kamble RT, Schears R, Olsson RF, Hayashi RJ, Gale RP, Mayo SJ, Chhabra S, Rotz SJ, Badawy SM, Ganguly S, Pavletic S, Nishihori T, Prestidge T, Agrawal V, Hogan WJ, Inamoto Y, Shaw BE, Satwani P) Blood Adv 2020 May 12;4(9):2084-2094 PMID: 32396620 PMCID: PMC7218429 SCOPUS ID: 2-s2.0-85086114432 05/13/2020       24 Citations
  • Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia. (Eapen M, Zhang MJ, Tang XY, Lee SJ, Fei MW, Wang HL, Hebert KM, Arora M, Chhabra S, Devine SM, Hamadani M, D'Souza A, Pasquini MC, Phelan R, Rizzo JD, Saber W, Shaw BE, Weisdorf DJ, Horowitz MM) Biol Blood Marrow Transplant 2020 Jul;26(7):e161-e166 PMID: 32389803 PMCID: PMC7206419 SCOPUS ID: 2-s2.0-85084668943 05/12/2020       44 Citations
  • Developmental differences in health-related quality of life in adolescent and young adult cancer survivors. (Becktell K, Simpson P, Phelan R, Schmidt D, Anderson L, Nichols J, Bingen K) Qual Life Res 2020 Sep;29(9):2435-2444 PMID: 32323061 SCOPUS ID: 2-s2.0-85084090912 04/24/2020       7 Citations
  • Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis. (Hamadani M, Zhang MJ, Tang XY, Fei M, Brunstein C, Chhabra S, D'Souza A, Milano F, Phelan R, Saber W, Shaw BE, Weisdorf D, Devine SM, Horowitz MM) Biol Blood Marrow Transplant 2020 Jul;26(7):1312-1317 PMID: 32283185 PMCID: PMC7194895 SCOPUS ID: 2-s2.0-85083795044 04/14/2020       53 Citations
  • Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report. (Burroughs LM, Petrovic A, Brazauskas R, Liu X, Griffith LM, Ochs HD, Bleesing JJ, Edwards S, Dvorak CC, Chaudhury S, Prockop SE, Quinones R, Goldman FD, Quigg TC, Chandrakasan S, Smith AR, Parikh S, Dávila Saldaña BJ, Thakar MS, Phelan R, Shenoy S, Forbes LR, Martinez C, Chellapandian D, Shereck E, Miller HK, Kapoor N, Barnum JL, Chong H, Shyr DC, Chen K, Abu-Arja R, Shah AJ, Weinacht KG, Moore TB, Joshi A, DeSantes KB, Gillio AP, Cuvelier GDE, Keller MD, Rozmus J, Torgerson T, Pulsipher MA, Haddad E, Sullivan KE, Logan BR, Kohn DB, Puck JM, Notarangelo LD, Pai SY, Rawlings DJ, Cowan MJ) Blood 2020 Jun 04;135(23):2094-2105 PMID: 32268350 PMCID: PMC7273831 SCOPUS ID: 2-s2.0-85086008168 04/09/2020       101 Citations
  • Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemia. (Lee CJ, Kim S, Tecca HR, Bo-Subait S, Phelan R, Brazauskas R, Buchbinder D, Hamilton BK, Battiwalla M, Majhail NS, Lazarus HM, Shaw PJ, Marks DI, Litzow MR, Chhabra S, Inamoto Y, DeFilipp Z, Hildebrandt GC, Olsson RF, Kasow KA, Liesveld JL, Rotz SJ, Badawy SM, Bhatt NS, Yared JA, Page KM, Arellano ML, Kent M, Farhadfar N, Seo S, Hematti P, Freytes CO, Rovó A, Ganguly S, Nathan S, Burns L, Shaw BE, Muffly LS) Blood Adv 2020 Mar 24;4(6):983-992 PMID: 32168378 PMCID: PMC7094022 SCOPUS ID: 2-s2.0-85082533373 03/14/2020       40 Citations
  • Upfront Therapies and Downstream Effects: Navigating Late Effects in Childhood Cancer Survivors in the Current Era. (Phelan R, Eissa H, Becktell K, Bhatt N, Kudek M, Nuechterlein B, Pommert L, Tanaka R, Baker KS) Curr Oncol Rep 2019 Nov 25;21(12):104 PMID: 31768799 SCOPUS ID: 2-s2.0-85075563534 11/27/2019       4 Citations
  • Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT. (Marsh RA, Leiding JW, Logan BR, Griffith LM, Arnold DE, Haddad E, Falcone EL, Yin Z, Patel K, Arbuckle E, Bleesing JJ, Sullivan KE, Heimall J, Burroughs LM, Skoda-Smith S, Chandrakasan S, Yu LC, Oshrine BR, Cuvelier GDE, Thakar MS, Chen K, Teira P, Shenoy S, Phelan R, Forbes LR, Chellapandian D, Dávila Saldaña BJ, Shah AJ, Weinacht KG, Joshi A, Boulad F, Quigg TC, Dvorak CC, Grossman D, Torgerson T, Graham P, Prasad V, Knutsen A, Chong H, Miller H, de la Morena MT, DeSantes K, Cowan MJ, Notarangelo LD, Kohn DB, Stenger E, Pai SY, Routes JM, Puck JM, Kapoor N, Pulsipher MA, Malech HL, Parikh S, Kang EM, submitted on behalf of the Primary Immune Deficiency Treatment Consortium) J Clin Immunol 2019 Oct;39(7):653-667 PMID: 31376032 PMCID: PMC6754755 SCOPUS ID: 2-s2.0-85072546464 08/04/2019       45 Citations
  • What is the Role of Hematopoietic Cell Transplantation (HCT) for Pediatric Acute Lymphoblastic Leukemia (ALL) in the Age of Chimeric Antigen Receptor T-Cell (CART) Therapy? (Taraseviciute A, Broglie L, Phelan R, Bhatt NS, Becktell K, Burke MJ) J Pediatr Hematol Oncol 2019 Jul;41(5):337-344 PMID: 30973486 SCOPUS ID: 2-s2.0-85064242570 04/12/2019       17 Citations
  • Development of Secondary Osteosarcoma After TBI and Allogeneic Bone Marrow Transplant: A Case Series of 3 Patients. (Scheuermann A, Phelan R, Browning M) J Pediatr Hematol Oncol 2020 Mar;42(2):e100-e103 PMID: 30807391 SCOPUS ID: 2-s2.0-85062182789 02/27/2019       3 Citations
  • Sequential transplantation and implications for clinical management: OLT followed by HCT and consequent RT in a pediatric patient. (Hoogenboom L, Margolis D, Anderson L, Phelan R) Pediatr Transplant 2019 May;23(3):e13370 PMID: 30779289 SCOPUS ID: 2-s2.0-85061909142 02/20/2019    
  • First report that prior ECMO therapy does not preclude hematopoietic cell transplantation. (Broglie L, Phelan R, Talano JA) Pediatr Hematol Oncol 2018 May;35(4):245-249 PMID: 30570427 SCOPUS ID: 2-s2.0-85059008833 12/21/2018       1 Citation
  • Post-transplantation employment status of adult survivors of childhood allogeneic hematopoietic cell transplant: A report from the Center for International Blood and Marrow Transplant Research (CIBMTR). (Bhatt NS, Brazauskas R, Tecca HR, Carreras J, Burns LJ, Phelan R, Salit RB, Syrjala KL, Talano JM, Shaw BE) Cancer 2019 Jan 01;125(1):144-152 PMID: 30368771 PMCID: PMC6310211 SCOPUS ID: 2-s2.0-85055708918 10/29/2018       20 Citations
  • Post-transplant adaptive function in childhood cerebral adrenoleukodystrophy. (Pierpont EI, McCoy E, King KE, Ziegler RS, Shanley R, Nascene D, Raymond GV, Phelan R, Lund TC, Orchard PJ, Miller WP) Ann Clin Transl Neurol 2018 Mar;5(3):252-261 PMID: 29560371 PMCID: PMC5846389 SCOPUS ID: 2-s2.0-85043481298 03/22/2018       11 Citations
  • Successful hematopoietic cell transplantation following cardiac transplantation in two pediatric patients. (Phelan R, Smith AR, Orchard PJ, Ameduri RK) Pediatr Transplant 2018 Mar;22(2) PMID: 29352516 SCOPUS ID: 2-s2.0-85040738598 01/21/2018       1 Citation
  • Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis. (Broglie L, Pommert L, Rao S, Thakar M, Phelan R, Margolis D, Talano J) Blood Adv 2017 Aug 22;1(19):1533-1536 PMID: 29296794 PMCID: PMC5728466 SCOPUS ID: 2-s2.0-85040141428 01/04/2018       112 Citations
  • When Less Is Good, Is None Better? The Prognostic and Therapeutic Significance of Peri-Transplant Minimal Residual Disease Assessment in Pediatric Acute Lymphoblastic Leukemia. (Lamble A, Phelan R, Burke M) J Clin Med 2017 Jul 07;6(7) PMID: 28686179 PMCID: PMC5532574 SCOPUS ID: 2-s2.0-85053069538 07/08/2017       11 Citations
  • The role of hematopoietic stem-cell transplantation in first remission in pediatric acute lymphoblastic leukemia: a narrative review (Bhatt NS, Phelan R, Burke MJ) J Pediatr Rev 05/15/2017    
  • Neonatal Respiratory Failure Caused by Congenital Diffuse Intrinsic Pontine Glioma. (Satrom KM, Phelan RA, Moertel CL, Brent Clark H, Johnson DE, George TN) J Child Neurol 2017 May;32(6):533-536 PMID: 28116951 SCOPUS ID: 2-s2.0-85018791120 01/25/2017       4 Citations
  • Ovarian function after hematopoietic cell transplantation: a descriptive study following the use of GnRH agonists for myeloablative conditioning and observation only for reduced-intensity conditioning. (Phelan R, Mann E, Napurski C, DeFor TE, Petryk A, Miller WP, Wagner JE, Verneris MR, Smith AR) Bone Marrow Transplant 2016 Oct;51(10):1369-1375 PMID: 27272448 PMCID: PMC5299542 SCOPUS ID: 2-s2.0-84976288626 06/09/2016       28 Citations
    • Last update: 07/01/2025